A new study from the Stein Eye Institute resolves the long-standing debate on the structural question of primate cone photoreceptors' disk membranes. Researchers found that the majority of disk membranes are closed, unlike non-mammalian species, with implications for cell biological processes and phototransduction.
Researchers identified three amino acid changes that account for the 30 nm difference in light absorption between red and green cone pigments, enabling precise color discrimination. The study's findings may inform future drug discovery efforts targeting visual photoreceptors.
Researchers discovered a unique photoreceptor cell that optimizes vision in low-light conditions, combining the benefits of both cone and rod cells. This finding has potential applications in developing more efficient cameras and medical treatments for eye conditions such as glaucoma.
Researchers discover Dscamb protein regulates spacing between color-detecting cells, ensuring perfect arrangement for optimal vision. The protein acts as a 'self-avoidance enforcer' to maintain proper distances between cone cells.
Researchers used fMRI to assess brain responses to lights stimulating only cone cells in dogs with different types of retinal diseases. The study found that gene augmentation therapy restored response in cortex to black and white stimulation, making this disease a promising one for photoreceptor cell replacement treatment.
Researchers have provided new insights into the role of lipid droplet-localized CETN-SPDL1-L in regulating cone cell lipid droplet localization, crucial for light sensitivity. The study discovered centrin proteins and SPDL1-L collaborate to maintain correct lipid droplet placement.
Researchers discovered that a certain short-wave or blue sensitive cone circuit is absent in marmosets and differs from the macaque monkey's circuit. This finding suggests that humans have unique neural wiring for color vision that may be linked to recent evolutionary adaptations.
A new study has partly restored the function of retina's cone receptors in two completely colorblind children using gene therapy. The treatment has been shown to activate previously dormant communication pathways between the retina and brain, drawing on the plastic nature of the developing adolescent brain.
Researchers found that mitochondria act as microlenses to focus light on outer segments where it's converted into nerve signals, shedding new light on the retina's optical properties. This discovery has potential clinical implications for detecting retinal diseases.
New research in zebrafish reveals the genetic mechanisms behind blue and green color vision loss in human ancestors. By studying gene editing tools and genome sequencing, experts understand how genes are regulated to detect different light wavelengths.
Researchers at Penn Medicine delivered a new gene therapy that improved vision in three patients with severe vision impairments. The therapy showed sustained improvements in day and night vision, without serious side effects.
A gene therapy protects eye cells in mice with a rare disorder, suggesting a combination approach may preserve vision in people with retinitis pigmentosa. Researchers found that using Txnip gene therapies, along with treatments for oxidative stress and inflammation, provided additional protection for the cells.
A new gene therapy approach has been successful in restoring both normal structure and function to the retina's cone photoreceptor cells in dogs with a severe form of Leber congenital amaurosis. The treatment, which delivered a normal copy of the NPHP5 gene, was tested in nine five-week-old dogs and showed promising results.
A new imaging method has been developed that can capture high-resolution images of photoreceptors in the human eye, overcoming resolution limitations imposed by light diffraction. The technique uses annular pupil illumination and sub-Airy detection to enhance microscopy techniques for earlier detection and treatment of eye diseases.
A new study by NIH scientists reveals that prion disease affects the eye first, specifically targeting cone photoreceptor cells. The researchers used confocal microscopy to identify prion protein deposits in cones and rods, finding early damage in cilia and ribbon synapses.
Researchers found that deleting FATP4 increases cone photoreceptor survival and visual function nearly 10-fold in mouse models of Leber congenital amaurosis. This discovery establishes FATP4 as a promising therapeutic target to preserve daytime color vision in patients with RPE65 gene mutations.
Researchers discovered a pigment called melanopsin sensitive to blue light affects circadian rhythms but cone photoreceptors respond strongly to long wavelength oranges and yellows at sunrise and sunset. The study identifies a cell in the retina regulating brain centers that impact sleep, mood and learning.
Researchers have identified glial and vascular cells as contributing to the development of age-related macular degeneration, a leading cause of blindness in the elderly. The study provides new insights into the disease, highlighting potential targets for novel therapies.
Scientists inserted a green-light receptor gene into the eyes of blind mice and, a month later, they regained sight. The researchers aim to develop this therapy for humans within three years, potentially restoring their ability to read or watch video.
Retinoblastoma arises from abnormal proliferation of cone cells due to a tumor-suppressing gene mutation. Dr. Cobrinik's research aims to understand how RB mutations affect cone cells, which could lead to new cancer therapies.
Researchers used a mathematical model to determine how cone cells in zebrafish arrange themselves into specific patterns. Small defects in the patterns lead to only one of two possible arrangements, emerging from differences in adhesion force between cells.
New research finds that suppressing thyroid hormone receptor activity locally in the retina protects cone photoreceptor cells, slowing cell death and prolonging their life span. The study suggests a therapeutic strategy for treating retinal degeneration using topical medications or eyedrops.
Researchers at University of California San Diego use CRISPR/Cas9 to reprogram mutated rod photoreceptors into functioning cone photoreceptors, reversing cellular degeneration and restoring visual function in two mouse models of retinitis pigmentosa. The approach shows promise for advancing human clinical trials.
Researchers have identified a key gene in zebrafish that causes congenital blindness, which could hold the key to treating a similar disease in humans. The study found that the gene affects cone photoreceptors and leads to degeneration without impacting rod cells.
Researchers uncovered the fovea's computational architecture and basic visual processing, distinct from other regions of the retina. This discovery helps explain differences in central and peripheral vision qualities.
A genetic mutation in whale eyes impairs their ability to see in bright light, making them more susceptible to fatal entanglements in fishing gear. This study may also provide insight into how vision works in other mammals, including humans.
Researchers at Penn University have found remarkable similarities between human Leber congenital amaurosis and canine blinding disease Senior Løken Syndrome. The diseases share the same causative gene, NPHP5, and display similar pathology. The study's findings offer promising results for developing therapies to treat these conditions.
In early mammals, rods in the mammalian eye developed from color-detecting cone cells, giving them an edge in low-light conditions. This evolution allowed early mammals to take up a nocturnal lifestyle and survive as predators were dominant during the day.
A CHLA researcher has been awarded a four-year grant to study the development of cone photoreceptors in the retina, which can lead to devastating vision loss due to diseases like retinoblastoma. The goal is to improve modeling of these diseases and develop novel therapies using human embryonic stem cell-derived retina models.
A new technique using human embryonic stem cells has been developed by Professor Gilbert Bernier, allowing for the production of light-sensitive retina cells. This breakthrough could lead to treatments for currently non-curable eye diseases like Stargardt disease and age-related macular degeneration.
Researchers at Children's Hospital Los Angeles discovered the origin of retinoblastoma tumors in young children, revealing a single genetic change in the RB1 gene. This finding holds promise for developing novel therapies and advancing understanding of cancer development.
Researchers have identified a fovea-like region in dogs' retina with high cone density, similar to that of humans, and found it susceptible to genetic blinding diseases. This discovery has promising implications for translational research into human foveal and macular degenerative diseases.
A groundbreaking study has identified the mode of death of cone photoreceptor cells in an animal model of retinitis pigmentosa. The receptor interacting protein (RIP) kinase pathway is found to be involved in cone degeneration, and a deficiency of RIP kinase reduces cone loss.
Sharks lack color vision due to having only one type of long-wavelength-sensitive cone cell in their retina. This finding may help prevent shark attacks and improve fishing gear design.
Researchers have found that rod cells in the retina play a crucial role in setting internal biological clocks, even in low light conditions. This discovery has important implications for understanding circadian rhythms and sleep disorders, particularly in older adults who may lose their rod cells to age.
Vision scientists at Washington University School of Medicine identified a process that allows the human eye to adapt to darkness quickly, also enabling it to function in bright light. This discovery may contribute to better understanding of age-related macular degeneration and potential treatments.
Researchers from the University of Florida and the University of Washington successfully used gene therapy to restore color vision in two squirrel monkeys. The study demonstrates the potential for this treatment to target adult vision disorders involving cone cells, a crucial step towards developing therapies for human cone diseases.
Researchers found bats possess two spectral cone photoreceptor types for daylight and colour vision, as well as increased sensitivity to UV light in cone-stimulating conditions. This adaptation is expected to improve visual orientation at twilight, predator avoidance, and flower detection.
Researchers at Johns Hopkins Medicine have identified a new type of light-sensitive cell in the retina of fish, which challenges current knowledge about retinal function and image vision. This discovery reveals that horizontal cells, previously thought to be only responsive to neighboring nerve cells, can also sense light.
Scientists have discovered a key to eye development - a protein called Pias3 that promotes rod cell formation and suppresses cone cell development. This breakthrough could lead to new treatment options for blinding conditions such as macular degeneration.
A team of Johns Hopkins neuroscientists has discovered a new type of light sensor in the eye that detects light and communicates with the brain. These melanopsin-containing cells are insensitive to light, but their signal is large enough to influence the brain when activated by multiple photons.
Scientists at the Salk Institute discovered that eliminating a third light sensor called melanopsin leaves mammals' circadian clocks blind to light but preserves perfect vision. This finding may lead to new treatments for jet lag, insomnia, and depression by resetting the body's biological clock.
A recent study examines the remarkable two-tone color of pumpkin seed oil using imaging and CIE chromaticity coordinates. The observed color shift from red to green is attributed to changes in oil layer thickness and unique human retina cell characteristics.
Researchers successfully engineered mice to see colors beyond the normal range by introducing a single human gene that codes for a light sensor. This breakthrough demonstrates the flexibility of the mammalian brain in processing sensory information, opening new avenues for understanding the evolution of color vision.
Scientists at Johns Hopkins have successfully blocked the advance of retinal degeneration in mice with antioxidants, including vitamin E and alpha-lipoic acid. The study found that high oxygen levels in the retina kill cone photoreceptors, which are critical to central vision.
Intrinsically photosensitive retinal ganglion cells (ipRGCs) adapt to lighting conditions, sending signals about overall brightness to the brain. This adaptation allows ipRGCs to regulate pupil size and circadian rhythms.
Researchers found that deuteranomalous individuals can distinguish between colors inaccessible to normal color vision, suggesting a unique color dimension. This discovery challenges the long-held assumption that colorblindness is solely related to reduced color perception.
Researchers found that mice lacking integrin have impaired rod cell uptake, but can still collect debris; a protein trigger is needed to initiate digestion. Synchronizing timing scavenging may be key to maintaining proper cellular function and preventing age-related blindness.
Researchers at EMBL have discovered that the light-sensitive cells in our eyes, rods and cones, originated from an ancient population of light-sensitive cells located in the brain. These brain cells were later recruited for vision, leading to the evolution of the human eye.
A newly discovered light detection system in the eye helps set the body's internal clock, regulate general activity levels, and control pupil size. This system is based on a molecule sensitive to blue light called opsin, which works differently from traditional rod and cone systems.
A team of international researchers led by Johns Hopkins scientists has discovered that the eye's ability to detect light is carried out by just three cell types: rods, cones, and melanopsin-producing cells. This finding resolves years of controversy and sheds new light on the eye's non-visual functions.
Researchers have discovered that a specific subset of retinal ganglion cells, containing the protein melanopsin, play a vital role in detecting light and controlling the pupil's response. Without melanopsin, the pupil fails to constrict fully in bright light.
Researchers at Brown University have identified a new photoreceptor cell in the eye that turns light energy into brain signals, governing the body's 24-hour clock and helping people adjust to jet lag. This discovery expands our understanding of visual systems, suggesting a parallel system to the well-known rods and cones.
Researchers have made a breakthrough discovery about the development of rod and cone photoreceptors, the light-sensitive cells in the retina that initiate vision. The study found that the retinal protein Nrl acts as a 'molecular switch,' signaling cells to develop into rods rather than cones.
Researchers at Max Planck Institute found that moving objects appear slower through rod photoreceptors than cone photoreceptors, especially under low light conditions. This underestimation can lead to compensatory speeding-up, which may be fatal.